Vimarsana
Biggest News Aggregation in the World

Page 27 - Cellular Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Therapy Today - Breaking & Trending Today

Syncromune® Inc. Expands Scientific Advisory Board with Addition of Prominent Oncology Trailblazer James Armitage, M.D. - Vimarsana News

Syncromune® Inc. Expands Scientific Advisory Board with Addition of Prominent Oncology Trailblazer James Armitage, M.D.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Oct 31, 2023--

FDA advisers see no roadblocks for gene-editing treatment for sickle cell disease - Vimarsana News

FDA advisers see no roadblocks for gene-editing treatment for sickle cell disease

Advisers to the Food and Drug Administration meeting Tuesday paved the way for the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline.

Source: kpbs.org
FDA advisers see no roadblocks for gene-editing treatment for sickle cell disease - Vimarsana News

FDA advisers see no roadblocks for gene-editing treatment for sickle cell disease

Advisers to the Food and Drug Administration meeting Tuesday paved the way for the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline.

Source: wysu.org
Success of Gene Therapy Relies on Integration Location in DNA - Vimarsana News

Success of Gene Therapy Relies on Integration Location in DNA

The location of integration of a gene therapy has been crucial for the safety and efficacy of the treatment to cure infants with X-linked severe combined immunodeficiency.

Source: ajmc.com
Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes (LR-MDS) - Vimarsana News

Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes (LR-MDS)

/PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies addressing...